✦ LIBER ✦

Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy

✍ Scribed by Noah Rodriguez; J. Alejandro Rauh-Hain; Melina Shoni; Ross S. Berkowitz; Michael G. Muto; Colleen Feltmate; John O. Schorge; Marcela G. del Carmen; Ursula A. Matulonis; Neil S. Horowitz

Book ID: 113964059
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 335 KB
Volume: 125
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2012.02.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CA-125 changes can predict optimal inter

CA-125 changes can predict optimal interval cytoreduction in patients with advanced-stage epithelial ovarian cancer treated with neoadjuvant chemotherapy

✍ N. Rodriguez; J. Rauh-Hain; C. Feltmate; M. Del Carmen; R. Penson; A. Goodman; U 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 108 KB

A Gynecologic Oncology Group Study of se

A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172

✍ Thomas C. Krivak; Chunqiao Tian; G. Scott Rose; Deborah K. Armstrong; G. Larry M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 318 KB